CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 8 No. 4
 

Modified Respiratory Therapy for Advanced Cancer Patients

April 1, 1999

CLEVELAND—Standard respiratory therapy often must be modified for the palliative care patient, David Haney, RRT, said at a conference on palliative medicine held at the Cleveland Clinic Foundation.

National guidelines, developed by the American Association for Respiratory Care and the American Thoracic Society, define clinical indications and care plans for various modes of respiratory therapy, including aerosol therapy, bronchopul-monary hygiene, and hyperinflation therapy. However, these guidelines frequently fail to apply to patients with advanced cancer.

“The problem is that palliative care patients don’t necessarily fall into those neat categories,” said Mr. Haney, a clinical specialist with the Respiratory Therapy Consult Service at the Cleveland Clinic. “Palliative care patients may require a different set of indications, and modifications frequently must be made to the therapy itself if the patient is going to be able to tolerate it.”

Aerosol Therapy

Shortness of breath and dyspneic feelings are clinical indications for aerosol therapy in palliative care patients, Mr. Haney said. This differs from the clinical indications for aerosol therapy in the general population as described by the national guidelines. Those indications include bronchospasm, history of bronchospasm, thick proteinaceous secretions, and airway inflammation.

Aerosol therapy for patients in palliative care may be modified to include increased frequency of bronchodilator use, he said. Another modification is the use of aerosolized morphine(Drug information on morphine) treatment. Although the value of nebulized morphine continues to be widely debated, it has been shown to be effective in several small studies of patients with chronic lung disease and cardiac disease.

Bronchopulmonary Hygiene

Patients with advanced cancer who have rhonchi or a nonproductive cough may benefit from bronchopulmonary hygiene, which consists of percussion and vibrations, and suctioning.

Yet palliative care patients may experience pain from side-to-side percussion therapy. They may suffer discomfort from putting the head of the bed flat, which is typically done during bronchopulmonary hygiene.

In addition, certain types of lung cancer, or a platelet count of less than 50,000, are contraindications for percussion and vibrations, Mr. Haney commented.

Palliative care patients benefit from modifications to the bronchopulmonary hygiene plan. Modifications include using a mucolytic aerosol and suctioning with soft catheters. Postural drainage with gravity can also be used to assist in mobilizing secretions.

Hyperinflation Therapy

Hyperinflation therapy involves the use of a face mask and either IPPB (intermittent positive pressure breath) or CPAP (continuous positive airway pressure). Both of these therapies require the patient to increase the work of breathing. For this reason, the care plan may need to be modified for the fatigued cancer patient. Family members may also request therapy that is less aggressive than the use of a face mask and positive airway pressure.

Modifications that can be made include using a high-flow cascade of oxygen with a loose-fitting mask, Mr. Haney said. In addition, the health care provider may decide to accept lower levels of blood gases (PaO2 and SpO2) than the national standards call for. Rather than accept the national values of 90% to 100%, the provider may compromise to accept blood gas values in the low- to mid-80s.

These kinds of modifications demonstrate a need for protocols for the respiratory therapy of palliative care patients, Mr. Haney said. However, he added, further studies are required before such protocols can be developed.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy